Barbara Gini

Extended follow-up of invasive cervical cancer risk after quadrivalent HPV vaccination: nationwide, register based study Objectives To evaluate the long term risk of invasive cervical cancer after receiving the quadrivalent human papillomavirus (HPV) vaccine, how risk varies by time since vaccination, and to assess the ...

The HPV vaccine is durably AMAZING.A massive Swedish registry study w 18 years of follow-up found no waning protection against invasive cervical cancer. If vaccinated before age 17, cancer risk is cut by ~80%. Even those vaccinated later still had substantial protection.
www.bmj.com/content/392/...

I’m here for the bean posting… curious to see what else there is, at this point :)